Unlocking PTSD: From Single Cells to Improved Therapeutics
A Brain & Behavior Research Foundation Meet the Scientist Webinar
New York, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Scientists are uncovering PTSD at a level of detail never before possible. Using cutting-edge technologies that examine individual brain cells and the three-dimensional organization of DNA, researchers are uncovering how trauma reshapes the brain, revealing new biological targets that could lead to more effective and personalized treatments for people living with PTSD.
Join us on October 13, 2026, at 2pm ET for a free webinar, “Unlocking PTSD: From Single Cells to Improved Therapeutics” to learn more about these groundbreaking discoveries. The guest speaker, Matthew J. Girgenti, Ph.D., is an associate professor of psychiatry at Yale School of Medicine, deputy director for research at the VA PTSD Brain Bank, and a recipient of two Young Investigator grants. The moderator, Jeffrey Borenstein, M.D., is President & CEO of the Brain & Behavior Research Foundation and host of the Emmy® nominated television series Healthy Minds.
Register Here to learn how new discoveries about the brain could lead to more effective and personalized treatments for PTSD.
About Brain & Behavior Research Foundation
The Brain & Behavior Research Foundation awards research grants to develop improved treatments, cures, and methods of prevention for mental illness. These illnesses include addiction, ADHD, anxiety, autism, bipolar disorder, borderline personality disorder, depression, eating disorders, OCD, PTSD, and schizophrenia, as well as research on suicide prevention. Since 1987, the Foundation has awarded more than $487 million to fund more than 5,900 leading scientists around the world. 100% of every dollar donated for research is invested in research. BBRF operating expenses are covered by separate foundation grants. BBRF is the producer of the Emmy®-nominated public television series Healthy Minds with Dr. Jeffrey Borenstein, which aims to remove the stigma of mental illness and demonstrate that with help, there is hope.
Attachments

Myrna Manners Brain & Behavior Research Foundation (718) 986-7255 [email protected]Source: Brain & Behavior Research Foundation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FTI Consulting Expands UK Turnaround & Restructuring Capabilities With Four Senior Hires
- Atrogi announces positive human data for ATR-258, its first-in-class, oral therapy designed to improve muscle function and body composition
- Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share